Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer

Prostate

Volumn 29, Issue SUPPL. 7, 1996, Pages 30-34

  Van Cangh, Paul J ^a   De Nayer, Philippe ^a   Sauvage, Philippe ^a   Tombal, Bertrand ^a   Elsen, Marc ^a   Lorge, Francis ^a   Opsomer, Reinier ^a   Wese, François X ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

antigens; differential diagnosis; neoplasms; prostatic hypertrophy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; CANCER SCREENING; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; ARTICLE; IMMUNOASSAY; MIDDLE AGED; PROSPECTIVE STUDY; PROSTATE TUMOR; ROC CURVE; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0030340578     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0045(1996)7+<30::aid-pros4>3.0.co;2-n     Document Type: Conference Paper

References (7)

1. Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Petterson K, Lovgren T: Prostate-specific antigen in serum occurs predominantly in complex with α 1-antichymotrypsin. Clin Chem 37:1618-1625, 1991.
2. Bangma CH, Kranse R, Blijenberg BG, Schröder FH: The value of screening tests in the detection of prostate cancer. Part 1: Results of a retrospective evaluation of 1726 men. Urology 46:773-778, 1995.
3. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB: Evaluation of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274:1214-1220, 1995.
4. Luderer AA, Chen YT, Soriano TF, Kramp WJ, Carlson G, Cuny C, Shaarp T, Smith W, Petteway J, Brawer MK, Thiel R: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 46: 187-194, 1995.
5. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, Oesterling JE: Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era. Urology 45:729-744, 1995.
6. Oesterling JE, Jacobsen SJ, Klee GG, Petterson K, Piironen T, Abrahamsson P, Stenman U, Dowell B, Lövgren T, Lilja H: Free, complexed and total serum prostate-specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154:1090-1095, 1995.
7. Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine [Review]. Clin Chem 39:561-577, 1993.